MX2024011198A - Activador de glucuronidasa, composicion farmaceutica, composicion comestible, y composicion oral - Google Patents

Activador de glucuronidasa, composicion farmaceutica, composicion comestible, y composicion oral

Info

Publication number
MX2024011198A
MX2024011198A MX2024011198A MX2024011198A MX2024011198A MX 2024011198 A MX2024011198 A MX 2024011198A MX 2024011198 A MX2024011198 A MX 2024011198A MX 2024011198 A MX2024011198 A MX 2024011198A MX 2024011198 A MX2024011198 A MX 2024011198A
Authority
MX
Mexico
Prior art keywords
composition
glucuronidase
activator
oral application
edible
Prior art date
Application number
MX2024011198A
Other languages
English (en)
Spanish (es)
Inventor
Shinichi Honda
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of MX2024011198A publication Critical patent/MX2024011198A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • A23V2400/413—Acidilactici
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2024011198A 2022-03-17 2024-09-12 Activador de glucuronidasa, composicion farmaceutica, composicion comestible, y composicion oral MX2024011198A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022042917 2022-03-17
PCT/JP2023/009929 WO2023176849A1 (ja) 2022-03-17 2023-03-14 グルクロニダーゼ活性剤、医薬組成物、食用組成物、及び経口用組成物

Publications (1)

Publication Number Publication Date
MX2024011198A true MX2024011198A (es) 2024-11-08

Family

ID=88023802

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024011198A MX2024011198A (es) 2022-03-17 2024-09-12 Activador de glucuronidasa, composicion farmaceutica, composicion comestible, y composicion oral

Country Status (7)

Country Link
EP (1) EP4509129A4 (https=)
JP (1) JPWO2023176849A1 (https=)
KR (1) KR20250006837A (https=)
CN (1) CN119013031A (https=)
AU (1) AU2023233349A1 (https=)
MX (1) MX2024011198A (https=)
WO (1) WO2023176849A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025231132A1 (en) * 2024-04-30 2025-11-06 Kaneka Americas Holding, Inc. Probiotic strain for weight management
CN118726138B (zh) * 2024-06-06 2025-04-04 福建中益制药有限公司 一种短促生乳杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041125U (ja) 1983-08-29 1985-03-23 富士ロビン株式会社 背負式刈払機の伝動部におけるフレキシブル伝動軸の取付構造
JP4627555B2 (ja) 2008-08-07 2011-02-09 本田技研工業株式会社 車体構造
CN102905712B (zh) 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
JP6041125B2 (ja) 2012-07-06 2016-12-07 株式会社あすか製薬メディカル エストロゲンの超高感度測定法
EA201990630A1 (ru) * 2016-10-03 2019-10-31 Устойчивые к антисептику молочнокислые бактерии
KR102107443B1 (ko) * 2018-08-31 2020-05-07 (주)바이오리듬 여성 갱년기 증상 예방 또는 치료용 유산균 프로바이오틱스 제제
JP7604168B2 (ja) 2020-09-03 2024-12-23 ブラザー工業株式会社 画像形成方法および画像形成装置
CN113249256B (zh) * 2021-05-18 2023-04-28 江南大学 一株缓解雌激素相关代谢紊乱及肥胖的植物乳杆菌及应用

Also Published As

Publication number Publication date
CN119013031A (zh) 2024-11-22
WO2023176849A1 (ja) 2023-09-21
KR20250006837A (ko) 2025-01-13
EP4509129A4 (en) 2026-03-04
AU2023233349A1 (en) 2024-10-10
EP4509129A1 (en) 2025-02-19
JPWO2023176849A1 (https=) 2023-09-21

Similar Documents

Publication Publication Date Title
MX2024011198A (es) Activador de glucuronidasa, composicion farmaceutica, composicion comestible, y composicion oral
WO2002058690A3 (en) Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
AP1739A (en) Azaindoles
EP4609865A3 (en) Nlrp3 inhibitors
UA84271C2 (en) Formate salt of o-desmethyl-venlafaxine
AU3451797A (en) Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
PL370292A1 (en) Formulations for oral administration of active compounds
MX2023011464A (es) Inhibidores de la cinasa relacionada con el gen nunca en mitosis a 7 (nek7).
EP4424806A3 (en) Particles including bacterial endospores
DE60215139D1 (en) Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
WO2023054732A3 (ja) 新型コロナウイルス感染症治療用医薬
MX2025007457A (es) Composiciones blanqueadoras orales de peroximonosulfato
MX2023002864A (es) Composiciones blanqueadoras orales de peroximonosulfato.
MX2025003568A (es) Compuestos y composiciones útiles como inhibidores de las proteínas inhibidoras de la apoptosis (iap)
GEAP202516246A (en) Magl inhibitor
TW200504199A (en) Method of preventing lipids constituting lipid membrane from degradation and use thereof
WO2023137403A3 (en) Compound comprising raltitrexed or 5-mthf linked to a therapeutic agent, composition, and method of use
MX2026001801A (es) Compuesto y conjugado anticuerpo-farmaco que lo contiene
WO2022131880A3 (ko) 2종 이상의 서로 다른 조성물을 함유한 제제학적으로 안정한 연질캡슐제
ZA987436B (en) Method of increasing oral bioavailability of compounds
WO2020210521A3 (en) Compositions and methods for increasing muscle mass and oxidative metabolism
MXPA03010055A (es) Analogos de 17-metileno-androstan-3a-ol como inhibidores de hlc.
WO2023130146A3 (en) Cellular uptake peptide-therapeutic payload compositions and methods of use
MX2023002863A (es) Composiciones blanqueadoras orales de peroximonosulfato.
PH22023050211U1 (en) COMPOSITION OF KAMIAS (Averrhoa bilimbi) JAM